Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia

被引:209
作者
Tobin, G
Thunberg, U
Karlsson, K
Murray, F
Laurell, A
Willander, K
Enblad, G
Merup, M
Vilpo, J
Juliusson, G
Sundström, C
Söderberg, O
Roos, G
Rosenquist, R [1 ]
机构
[1] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden
[2] Uppsala Univ, Dept Oncol, SE-75185 Uppsala, Sweden
[3] Uppsala Univ, Dept Radiol, SE-75185 Uppsala, Sweden
[4] Uppsala Univ, Dept Clin Immunol, SE-75185 Uppsala, Sweden
[5] Linkoping Univ Hosp, Dept Hematol, S-58185 Linkoping, Sweden
[6] Linkoping Univ, Dept Biomed & Surg, Linkoping, Sweden
[7] Karolinska Univ Hosp, Dept Hematol, Huddinge, Sweden
[8] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland
[9] Tampere Univ Hosp, Dept Clin Chem, Tampere, Finland
[10] Umea Univ, Dept Med Biosci, Umea, Sweden
关键词
D O I
10.1182/blood-2004-01-0132
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We recently identified a chronic lymphocytic leukemia (CLL) subgroup using the immunoglobulin variable heavy-chain (V-H) gene V(H)3-21 with almost identical heavychain complementarity determining region 3s (HCDR3s) and preferential variable light-chain (V-L) gene usage, suggesting recognition of a common antigen epitope in this subset. To further explore the B-cell receptors (BCRs) in CLL, we characterized 407 V-H rearrangements amplified from 346 CLLs regarding V-H, diversity (D), and joining (J(H)) gene usage and performed multiple alignment of the HCDR3 sequences. These analyses revealed 3 small subsets (2 V(H)1-69 groups, 7 cases; and 1 V(H)1-2 group, 5 cases) with highly restricted HCDR3 features including identical V-H/D/J(H) usage, HCDR3 lengths, and shared N-sequences, in addition to the V(H)3-21 group (22 cases). Furthermore, another 3 groups (9 V(H)1-3(+) cases, 3 V(H)i-18(+) cases, and 5 V(H)4-39(+) cases) had essentially identical V-H/D/J(H) use and similar HCDR3 lengths but less conserved N-regions. Analysis in all 6 of these subgroups showed restriction in V-L gene use, whereas no association be-tween V-H and V-L usage was found in cases without HCDR3 similarities. Altogether, structurally similar HCDR3s associated with preferential V-L gene usage implies selection of BCRs, especially in subsets showing high HGDR3 similarities, thus pointing to restricted antigen recognition sites and possibly involvement of specific antigens in CLL development. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:2879 / 2885
页数:7
相关论文
共 39 条
[1]  
Albesiano E, 2003, BLOOD, V102, p664A
[2]   Analysis of the human V-H gene repertoire - Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM(+) and CD5(-)/IgM(+) B cells [J].
Brezinschek, HP ;
Foster, SJ ;
Brezinschek, RI ;
Dorner, T ;
DomiatiSaad, R ;
Lipsky, PE .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) :2488-2501
[3]   THE HUMAN-IMMUNOGLOBULIN V-H REPERTOIRE [J].
COOK, GP ;
TOMLINSON, IM .
IMMUNOLOGY TODAY, 1995, 16 (05) :237-242
[4]  
*CTR PROT ENG, 2004, E COMMUNICATION JAN
[5]   Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia [J].
Damle, RN ;
Wasil, T ;
Fais, F ;
Ghiotto, F ;
Valetto, A ;
Allen, SL ;
Buchbinder, A ;
Budman, D ;
Dittmar, K ;
Kolitz, J ;
Lichtman, SM ;
Schulman, P ;
Vinciguerra, VP ;
Rai, KR ;
Ferrarini, M ;
Chiorazzi, N .
BLOOD, 1999, 94 (06) :1840-1847
[6]  
Duke VM, 2003, HAEMATOLOGICA, V88, P1259
[7]   Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors [J].
Fais, F ;
Ghiotto, F ;
Hashimoto, S ;
Sellars, B ;
Valetto, A ;
Allen, SL ;
Schulman, P ;
Vinciguerra, VP ;
Rai, K ;
Rassenti, LZ ;
Kipps, TJ ;
Dighiero, G ;
Schroeder, HW ;
Ferrarini, M ;
Chiorazzi, N .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (08) :1515-1525
[8]  
Geiger KD, 2000, EUR J IMMUNOL, V30, P2918, DOI 10.1002/1521-4141(200010)30:10<2918::AID-IMMU2918>3.0.CO
[9]  
2-C
[10]   Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia [J].
Ghiotto, F ;
Fais, F ;
Valetto, A ;
Albesiano, E ;
Hashimoto, S ;
Dono, M ;
Ikematsu, H ;
Allen, SL ;
Kolitz, J ;
Rai, KR ;
Nardini, M ;
Tramontano, A ;
Ferrarini, M ;
Chiorazzi, N .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (07) :1008-1016